COVID-19

VUMC employees will still be able to get vaccines or boosters at the Occupational Health Clinic at Suite 640 in the Medical Arts Building.
March 30, 2023

One Hundred Oaks COVID-19 vaccination site to close April 7

The COVID-19 vaccination site at Vanderbilt Health One Hundred Oaks will close on April 7.

By VUMC News and Communications
March 23, 2023

COVID-19 vaccination site at One Hundred Oaks to close April 7

By Wayne Wood
March 23, 2023

Crowe’s research honored

Vanderbilt’s James Crowe Jr., MD, was among those to receive 2023 Advocacy Awards from Research!America at the biomedical research advocacy organization’s annual awards program in Washington, D.C.

By VUMC News and Communications
March 9, 2023

Study finds RSV may evade vaccines via rapid mutation

A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading.

By Bill Snyder
February 2, 2023

COVID-19 battle begins in the nose

A high upper airway concentration of the virus that causes COVID-19 was associated with changes in gene expression that could impact disease progression, Vanderbilt researchers discovered.

By Sarah E. Glass
January 26, 2023

Study to explore COVID’s impact on essential workers

Vanderbilt researchers are inviting non-health care essential workers to participate in a study to better understand how they continue to be impacted by COVID-19.

By Jill Clendening
January 19, 2023

Emerging Infections Program lands national award for COVID response

Vanderbilt's Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry.
By Jake Lowary
January 5, 2023

VUMC-led COVID-19 clinical trial platform goes international

The ACTIV-4 Host Tissue clinical trial platform, which is designed to investigate therapies targeting the host tissue response to COVID-19 to mitigate lung injury, is now being expanded internationally.
By Bill Snyder
January 4, 2023

VUMC strongly recommends COVID-19 bivalent booster vaccination as new COVID-19 variants appear in our region

With the development of new variants of the COVID-19 virus across the U.S. and the world, Vanderbilt University Medical Center recommends getting the bivalent booster vaccination.
By VUMC News and Communications
December 20, 2022

Reminder: COVID-19 bivalent boosters available through Occupational Health Clinic

By VUMC News and Communications
December 16, 2022

Bivalent booster vaccine effective in preventing COVID-19 hospitalization in older adults

The new bivalent mRNA COVID-19 booster vaccines that began being used in September are beneficial in preventing COVID-19-associated hospitalization in persons 65 and over.
By Craig Boerner
December 14, 2022

Surgical risk persists for patients who’ve had COVID

Vanderbilt researchers report that the trend of decreasing postoperative risk for people who have had COVID persists longer than previously known, for as long as 13 months after COVID.
By Paul Govern
November 10, 2022

AstraZeneca VP to discuss COVID-19 collaboration with VUMC Nov. 17

On Thursday, Nov. 17, Mark Esser, PhD, vice president, Early Vaccines and Immune Therapies R&D at AstraZeneca, will discuss his company’s collaboration with Vanderbilt University Medical Center that led to development of the Evusheld antibody combo to prevent COVID-19 in high-risk individuals.
By Bill Snyder
1 2 3 4 5 … 38